UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Physicians call for tighter control of botulinum toxin strains
by So Jae-hyeon
2018-04-12 16:33
Daewoong opens biotech research lab in Indonesia
by So Jae-hyeon
2018-04-12 11:37
Software expert to head Veeva Systems Korea
by So Jae-hyeon
2018-04-10 16:14
LG Chem, Merck to co-market hypertension drug
by So Jae-hyeon
2018-04-10 15:15
Biotech CEOs roll up sleeves for global biz
by So Jae-hyeon
2018-04-10 12:09
라인
Tamiflu crushed generic copies in flu season
by So Jae-hyeon
2018-04-09 15:40
Biosimilars take on original at breast cancer conference
by So Jae-hyeon
2018-04-09 15:05
Janssen, Hanmi start phase-2 study on obesity, diabetes drug
by So Jae-hyeon
2018-04-05 15:06
Korean biosimilars rarely prescribed in US
by So Jae-hyeon
2018-04-05 15:05
Will SGLT-2 combos with DPP-4 win insurance coverage?
by So Jae-hyeon
2018-04-04 15:12
라인
Outpatient drug prescriptions plunged in February
by So Jae-hyeon
2018-04-03 16:59
Steelmaker POSCO to challenge biotech sector
by So Jae-hyeon
2018-04-03 11:58
Chinese lab ends Olita deal with Hanmi
by So Jae-hyeon
2018-04-02 11:39
Daewoong, Yuhan in new rivalry to sell antidiabetic drugs
by So Jae-hyeon
2018-03-30 16:23
Dongkoo Bio inks deal to sell OTC prostate drug
by So Jae-hyeon
2018-03-29 14:18
라인
Drugmakers step up anti-fine dust marketing
by So Jae-hyeon
2018-03-28 11:35
Drugmakers seek partners to boost diabetes business
by So Jae-hyeon
2018-03-26 12:33
Pharmicell aims to test dendritic cell-based cancer drug this year
by So Jae-hyeon
2018-03-23 16:41
Myongji Hospital, Cancer Rop team up to fight cancer
by So Jae-hyeon
2018-03-23 15:48
Anticoagulant latecomer Lixiana outrivals Eliquis
by So Jae-hyeon
2018-03-22 16:12
-
1
2
3
4
5
6
7
8
9
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top